Oxeia Biopharmaceuticals develops novel therapeutics for patients with concussions.Because rest is not enough What’s New… Oxeia Biopharma In the News Podcaster Mandi Dickey and Oxeia CEO Michael Wyand talk everything concussion. Oxeia Biopharma named Most Innovative mTBI Biopharma Company 2025 by Global Health & Pharma These stories and more… Read more... Oxeia Biopharmaceuticals is a team of passionate scientists, biotech leaders, and athletes dedicated to bringing a safe and effective concussion therapy to market.REST IS NOT ENOUGH. More About What We Do